Walvax
Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture
Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture The company was listed on the GEM Board of China Shenzhen Stock Exchange in November 2010 (stock abbreviation: Watson Bio; stock code: 300142).
Cancer cell therapy company raised CNY 500 million in D round
Baiji Shenzhou PD-1 inhibitor price dropped by 80%
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Deyi sunshine completed tens of millions of Yuan round B financing
Novozyme plus R-CHOP Regimen for first-line treatment of mantle cell lymphoma
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Consumer Staples, Real Estate, Consumer DiscretionaryTech for Global, Globalization Footprints of the Established and the New
Jingtai technology has signed cooperation with new Geyuan to develop targeted drugs with AI and single cell sequencing as new tumor targets
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
Focus on high-throughput single-cell omics platform products, search for a reason to complete more than 100 million yuan round a financing
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Apr 01, 2021 04:39 PM
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
Sinopharm new coronavirus vaccine approved
Another protein component special medical food was approved, and the total number of approved products increased to 57
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
Phase I project of Guangzhou Pharmaceutical production base of nuocheng Jianhua was completed
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Asc41, a candidate drug for NASH, was administered to overweight and obese subjects in phase IB clinical trial
Fosun medicine: the new crown vaccine has been included in the domestic phase II clinical, and no serious adverse report has been received